Literature DB >> 1871127

The Rex regulatory protein of human T-cell lymphotropic virus type I binds specifically to its target site within the viral RNA.

T Unge1, L Solomin, M Mellini, D Derse, B K Felber, G N Pavlakis.   

Abstract

The Rex protein of human T-cell leukemia virus type I (HTLV-I) was expressed in bacteria and partially purified. Rex was shown to bind in vitro specifically to an RNA sequence located in the 3' long terminal repeat of HTLV-I, named Rex-responsive element (RXRE). Rex also bound in vitro to the human immunodeficiency virus type 1 (HIV-1) Rev-responsive element (RRE), while purified HIV-1 Rev protein did not bind to the RXRE. The binding results obtained in vitro are therefore in agreement with the nonreciprocal function of Rev and Rex in vivo. Rex binds specifically to both RRE and RXRE and activates expression in both HIV-1 and HTLV-I, while Rev binds to RRE and activates only HIV-1. Binding of Rex to RRE deletion mutants previously shown to lack either the Rev-responsive or the Rex-responsive portion suggested preferential binding of Rex to a distinct target within the RRE. These results demonstrated that Rex, like Rev, acts by binding to a specific RNA target.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1871127      PMCID: PMC52250          DOI: 10.1073/pnas.88.16.7145

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  Sequence-specific RNA binding by the HIV-1 Rev protein.

Authors:  M L Zapp; M R Green
Journal:  Nature       Date:  1989-12-07       Impact factor: 49.962

2.  Transcriptional (p40x) and post-transcriptional (p27x-III) regulators are required for the expression and replication of human T-cell leukemia virus type I genes.

Authors:  J Inoue; M Yoshida; M Seiki
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

3.  Expression of soluble, enzymatically active, human immunodeficiency virus reverse transcriptase in Escherichia coli and analysis of mutants.

Authors:  A Hizi; C McGill; S H Hughes
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

4.  Comparative analysis of the HTLV-I Rex and HIV-1 Rev trans-regulatory proteins and their RNA response elements.

Authors:  S M Hanly; L T Rimsky; M H Malim; J H Kim; J Hauber; M Duc Dodon; S Y Le; J V Maizel; B R Cullen; W C Greene
Journal:  Genes Dev       Date:  1989-10       Impact factor: 11.361

5.  Electrophoretic separation of complexes involved in the splicing of precursors to mRNAs.

Authors:  M M Konarska; P A Sharp
Journal:  Cell       Date:  1986-09-12       Impact factor: 41.582

6.  Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus.

Authors:  C A Rosen; E Terwilliger; A Dayton; J G Sodroski; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

7.  HTLV-I p27rex regulates gag and env protein expression.

Authors:  M C Dokhelar; H Pickford; J Sodroski; W A Haseltine
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1989

8.  The second pX product p27 chi-III of HTLV-1 is required for gag gene expression.

Authors:  J Inoue; M Seiki; M Yoshida
Journal:  FEBS Lett       Date:  1986-12-15       Impact factor: 4.124

9.  Functional analysis of CAR, the target sequence for the Rev protein of HIV-1.

Authors:  E T Dayton; D M Powell; A I Dayton
Journal:  Science       Date:  1989-12-22       Impact factor: 47.728

10.  Specific binding of HIV-1 recombinant Rev protein to the Rev-responsive element in vitro.

Authors:  T J Daly; K S Cook; G S Gray; T E Maione; J R Rusche
Journal:  Nature       Date:  1989-12-14       Impact factor: 49.962

View more
  23 in total

1.  Anti-Rex aptamers as mimics of the Rex-binding element.

Authors:  S Baskerville; M Zapp; A D Ellington
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

Review 2.  Mechanism of action of regulatory proteins encoded by complex retroviruses.

Authors:  B R Cullen
Journal:  Microbiol Rev       Date:  1992-09

3.  Specific binding of the human T-cell leukemia virus type I Rex protein to a short RNA sequence located within the Rex-response element.

Authors:  H P Bogerd; L S Tiley; B R Cullen
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

4.  Protein sequence requirements for function of the human T-cell leukemia virus type 1 Rex nuclear export signal delineated by a novel in vivo randomization-selection assay.

Authors:  H P Bogerd; R A Fridell; R E Benson; J Hua; B R Cullen
Journal:  Mol Cell Biol       Date:  1996-08       Impact factor: 4.272

Review 5.  T-cell control by human T-cell leukemia/lymphoma virus type 1.

Authors:  Genoveffa Franchini; Risaku Fukumoto; Jake R Fullen
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

6.  Polypyrimidine tract-binding protein and heterogeneous nuclear ribonucleoprotein A1 bind to human T-cell leukemia virus type 2 RNA regulatory elements.

Authors:  A C Black; J Luo; C Watanabe; S Chun; A Bakker; J K Fraser; J P Morgan; J D Rosenblatt
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

7.  Effects of translation initiation factor eIF-5A on the functioning of human T-cell leukemia virus type I Rex and human immunodeficiency virus Rev inhibited trans dominantly by a Rex mutant deficient in RNA binding.

Authors:  J Katahira; T Ishizaki; H Sakai; A Adachi; K Yamamoto; H Shida
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

8.  The Rev protein of human immunodeficiency virus type 1 promotes polysomal association and translation of gag/pol and vpu/env mRNAs.

Authors:  D M D'Agostino; B K Felber; J E Harrison; G N Pavlakis
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

9.  Definition of the human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type I Rex protein activation domain by functional exchange.

Authors:  I Weichselbraun; G K Farrington; J R Rusche; E Böhnlein; J Hauber
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

10.  Inhibitory activity of the equine infectious anemia virus major 5' splice site in the absence of Rev.

Authors:  W Tan; M Schalling; C Zhao; M Luukkonen; M Nilsson; E M Fenyö; G N Pavlakis; S Schwartz
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.